The HPV has been identified as the causative factor for the subset of head and neck cancer and for a last decades the constant increase of incidence of HPV positive cancer patients in Europe has been observed. The discussion about the treatment and outcome of these patients is one of the most up to date problems in head and neck oncology.
Furthermore, infections with cancer-causing human papillomaviruses (HPV) are becoming more and more common among patients.
During the symposium the most renowned experts in the field of surgery, radiotherapy, medical oncology and basic biology will exchange their knowledge and experience during challenging sessions and debates.
- 1st Symposium November 13-14, 2014 in Poznań (Poland).
- 2nd Symposium: November 3-4, 2016 in Leipzig (Germany).
Download the brochure.
Highlights from the Second International Symposium on HPV infection in head and neck cancer.
Wiegand S, Wichmann G, Golusinski W, Leemans CR, Klussmann JP, Dietz A.
Eur Arch Otorhinolaryngol. 2018 Jun;275(6):1365-1373 - 3rd Symposium: January 25-28, 2018 in Essen (Germany).
HNC2018_Program - HNC2018_Flyer - HNC2018_Abstract - 4th Symposium: November 5-6, 2020 in Amsterdam (Holland).
4th International Symposium on HPV Infection in
Head and Neck Cancer
10-11 November 2022
Amsterdam - the Netherlands
| Important deadlines | |
| 15 August 2022 | Deadline submission of abstracts |
| 1 September 2022 | Deadline early registration |
More info: Visit the website.
Organising committee
– René Leemans
– Ruud Brakenhoff
– Andreas Dietz
– Wojciech Golusinski